A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]
NYS Entity Status
NYS Filing Date
AUGUST 22, 2014
NYS DOS ID#
560 WHITE PLAINS RD
TARRYTO, NEW YORK, 10591
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - HOUSE OF TERRANCE, LLC
Around the Web
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Critic's Notebook: Contemporary Art Steams Up the Hudson
By NANCY PRINCENTHAL - Thursday Aug 24, 2017
Not your mother’s house tour: This summer has brought a bounty of artwork to Catskill, Hudson, Cold Spring and beyond.
- How a Home Bargain Became a ‘Pain in the Butt,’ and Worse
By MATTHEW GOLDSTEIN and ALEXANDRA STEVENSON - Friday Jul 7, 2017
A contract for deed, a seller-financed deal, can make it difficult to determine who owns a property, and who is responsible for paying taxes.